Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform

Histopathology
Alistair RobsonPhilip J Coates

Abstract

The p63 gene shares structural and functional homologies with the p53 family of transcriptional activators, but differs in exhibiting a consistent expression pattern in normal tissues. Although p63 is rarely mutated in malignancy studies of primary human tumours and cell lines suggest that p63 may promote tumour development. In non-Hodgkin's nodal lymphoma, TAp63 expression in follicular lymphoma (54%) and diffuse large B cell lymphoma (34%) has been described and correlated with the proliferative index. In this study, we analysed a series of primary cutaneous B cell lymphomas for immunohistochemical expression of p63. Thirty cases of diffuse large B cell lymphoma leg type (pcDLBCLL) and 34 cases of follicle centre cell lymphoma (pcFCCL) were stained using a generic antibody to p63, and a subset of these with an antibody specific for delta-Np63 isoform. The results indicate a significant difference between pcDLBCLL (21 of 30) and pcFCCL (four of 34) in p63 expression (P = 0.000); expression correlated strongly with the proliferation rate as assessed by Ki-67 (P = 0.015). None of the p63((+)) cases tested expressed the delta-Np63 isoform, suggesting that expression is of the TAp63 isoform. Functional studies are required to clar...Continue Reading

References

Mar 1, 1987·Journal of the American Academy of Dermatology·R WillemzeS C van der Putte
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J U RijlaarsdamR Willemze
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F A GeelenR Willemze
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·K HibiD Sidransky
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F GrangeR Willemze
Nov 16, 2002·The Journal of Pathology·Karin NylanderPhilip J Coates
Dec 6, 2003·The American Journal of Surgical Pathology·John R GoodladUNKNOWN Scotland and Newcastle Lymphoma Group
Feb 5, 2005·Blood·Rein WillemzeChris J L M Meijer
Jun 21, 2005·The Journal of Biological Chemistry·Mary MacPartlinHua Lu
Aug 6, 2005·Applied Immunohistochemistry & Molecular Morphology : AIMM·Cyrus V HedvatCharles J Di Como
Oct 15, 2005·Journal of Korean Medical Science·Chan-Kum Park, Young-Ha Oh
Aug 22, 2006·Cancer Science·Noriyasu FukushimaEisaburo Sueoka
Sep 12, 2007·Blood·Frida LantnerIdit Shachar
Dec 24, 2008·Journal of Clinical Pathology·A E Hallack NetoJ Pereira
Nov 16, 2010·Biochemical and Biophysical Research Communications·Jeng-Yuan Yao, Jan-Kan Chen
Jul 30, 2011·Science·Nicolas StranskyJennifer R Grandis
Oct 25, 2011·The Journal of Biological Chemistry·Tanusree SenDavid Sidransky
Apr 13, 2012·The Journal of Biological Chemistry·Yuan YaoChristophe Nicot
Apr 14, 2012·Leukemia & Lymphoma·Evguenia M Alexandrova, Ute M Moll
Jul 19, 2013·The Journal of Investigative Dermatology·Lianne KoensCornelis P Tensen
Sep 10, 2014·Sub-cellular Biochemistry·Kazushi Inoue, Elizabeth A Fry

❮ Previous
Next ❯

Citations

Sep 21, 2016·Case Reports in Hematology·Chelsey D DeelTeresa Scordino
Mar 28, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sarah MenguyAnne Pham-Ledard
Jul 25, 2019·Archives of Pathology & Laboratory Medicine·Alejandro A GruAndrea L Salavaggione
Mar 25, 2020·Advances in Anatomic Pathology·Andrew M Bellizzi
Nov 19, 2019·Pathology·Narittee SukswaiL Jeffrey Medeiros

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.